Currently, four such drugs available in the United States: exendin-4 or its synthetic version exenatide, liraglutide, albiglutide, and dulaglutide
Exclusion criteria included prematurity, being small for gestational age, neurological or psychiatric disorders, ADHD, movement disorders, syndromic short stature, additional pituitary hormone deficiency, known sleep disorder, known medical therapy for a chronic condition, or less than 6 months of growth hormone treatment
Infants and children with Down syndrome, displaying PWS-like hypotonia and delayed growth, were found to have significantly lower carnitine levels
Some compounded versions of peptides, including PT-141, are sold by gray-market retailers online, making them accessible to people without a prescription